EMA Authorised: Dynastat (parecoxib sodium) — Pfizer Europe MA EEIG

View source ↗

Summary

The EMA authorised Dynastat (parecoxib sodium) for postoperative pain management in the EU, with Pfizer Europe MA EEIG as the marketing authorization holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Dynastat

Snippet

Status: Authorised. Therapeutic area: Pain, Postoperative. MAH: Pfizer Europe MA EEIG. Decision date: 04/03/2025